Find any stock by ticker or company name
NCM – Цена в реальном времени. Валюта: USD
1.02
+0.01 (0.99%)
При закрытии: Jun 26, 2026, 4:00 PM EDT
1.00
-0.02 (-1.96%)
После закрытия: Jun 26, 2026, 6:11 PM EDT
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington.
| Имя | Должность |
|---|---|
| Dr. Sam Lee Ph.D. | Chief Scientific Officer, Co-Founder & President |
| Mr. James R. Sapirstein M.B.A., R.Ph. | Chief Executive Officer |
| Prof. Roger D. Kornberg Ph.D. | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board |
| Дата | Тип | Документ |
|---|---|---|
| 2026-06-09 | 8-K | form8-k.htm |
| 2026-06-03 | 8-K | form8-k.htm |
| 2026-05-27 | DEFA14A | formdefa14-a.htm |
| 2026-05-27 | DEF 14A | formdef14a.htm |
| 2026-05-26 | 8-K | form8-k.htm |
| 2026-05-15 | 10-Q | form10-q.htm |
| 2026-04-30 | 8-K | form8-k.htm |
| 2026-04-29 | CORRESP | filename1.htm |
| 2026-04-23 | S-3 | forms-3.htm |
| 2026-04-02 | 8-K | form8-k.htm |